Discontinuation report BELBUCA
Report ID | 80233 |
Drug Identification Number | 02465256 |
Brand name | BELBUCA |
Common or Proper name | Buprenorphine Buccal Soluble Film |
Company Name | PURDUE PHARMA |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUPRENORPHINE |
Strength(s) | 300MCG |
Dosage form(s) | FILM, SOLUBLE |
Route of administration | BUCCAL |
Packaging size | 60 |
ATC code | N02AE |
ATC description | OPIOIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2019-04-01 |
Actual discontinuation date | 2019-04-01 |
Remaining supply date | 2019-04-01 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | All stock has been depleted |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-04-01 | English | Compare |
v2 | 2019-04-01 | French | Compare |
v3 | 2019-04-02 | English | Compare |
Showing 1 to 3 of 3